ViewRay Announces FDA 510(k) Clearance for Advancements in MRI and Functional Imaging Technologies for MRIdian MRI-Guided Radiation Therapy System

Proprietary Technology from ViewRay Enables Imaging and Treatment Enhancements CLEVELAND, Feb. 21, 2019 -- (Healthcare Sales & Marketing Network) -- ViewRay, Inc. (Nasdaq: VRAY), announced today that the company received 510(k) clearance from the U.S. ... Devices, Oncology, Radiology, FDA ViewRay, MRIdian, MRI-guided, radiotherapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news